López MR, Suarez MC. Remission-driven discontinuation shapes the observed duration of emicizumab in acquired hemophilia A. Comment on: “Short-term emicizumab in patients with acquired hemophilia A”. haematol [Internet]. 2020Sep.10 [cited 2026Sep.15];. Available from: https://haematologica.org/article/view/14382